OSL:ELABS • NO0010722283
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ELLIPTIC LABORATORIES ASA (ELABS.OL).
| 2023 | 2024 | 2025 | 2026 | 2027 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 68.321M 31.23% | 131.914M 93.08% | 101.306M -23.20% | 220.42M 117.58% | 307.97M 39.72% | 439.33M | 505.03M 14.95% | 556.03M 10.10% | 600.16M 7.94% | 636.44M 6.05% | |
| EBITDA YoY % growth | -31.906M -8.33% | 27.603M 186.51% | -20.119M -172.89% | 86.52M 530.04% | 149.35M 72.62% | 254.97M | 303.02M 18.85% | 344.21M 13.59% | 384.41M 11.68% | 413.83M 7.65% | |
| EBIT YoY % growth | -48.13M -18.05% | 5.743M 111.93% | -45.444M -891.29% | 60.77M 233.73% | 118.45M 94.92% | 210.84M | 253.01M 20.00% | 289.29M 14.34% | 324.59M 12.20% | 350.09M 7.86% | |
| Operating Margin | -70.45% | 4.35% | -44.86% | 27.57% | 38.46% | 47.99% | 50.10% | 52.03% | 54.08% | 55.01% | |
| EPS YoY % growth | -0.36 -12.50% | 0.08 122.22% | -1.07 -1,437.50% | 0.49 146.21% | 0.91 83.33% | N/A | N/A | N/A | N/A | N/A |
All data in NOK
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in NOK
9 analysts have analysed ELABS.OL and the average price target is 19.38 NOK. This implies a price increase of 499.07% is expected in the next year compared to the current price of 3.235.
The consensus rating for ELLIPTIC LABORATORIES ASA (ELABS.OL) is 84.4444 / 100 . This indicates that analysts generally have a positive outlook on the stock.